HER2 Breast Cancer

>

Latest News

T-DXd/Pertuzumab Improves PFS in HER2+ Metastatic Breast Cancer
T-DXd/Pertuzumab Improves PFS in HER2+ Metastatic Breast Cancer

June 2nd 2025

T-DXd plus pertuzumab significantly extended PFS (40.7 vs 26.9 months) in HER2+ metastatic breast cancer, suggesting a new frontline standard of care.

AI Boosts Pathologist Accuracy in HER2-Low Breast Cancer
AI Boosts Pathologist Accuracy in HER2-Low Breast Cancer

May 22nd 2025

T-DXd Shows Benefits in Phase 3 Early Breast Cancer Study
T-DXd Shows Benefits in Phase 3 Early Breast Cancer Study

May 7th 2025

Runimotamab Plus Trastuzumab Shows Encouraging Activity and Tolerability in HER2-Positive Breast Cancer
Runimotamab Plus Trastuzumab Shows Encouraging Activity and Tolerability in HER2-Positive Breast Cancer

April 29th 2025

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Kentucky

View More

Breast Cancer Tumor Board®: Advancing Care in Metastatic Breast Cancer—The Evolving Role of Antibody-Drug Conjugates

View More

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

23rd Annual School of Breast Oncology

November 6-8, 2025

Register Now!

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

View More

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow

View More

The Inaugural Hawaii Breast Cancer: A Multidisciplinary Case-Based Conference

View More

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

Medical Crossfire®: Translating Evidence to Clinical Practice in Early-Stage HR+, HER2– Breast Cancer

View More

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

View More

Shaping Surgical Pathways: Revolutionizing Breast Cancer Care With Genetic Testing and Targeted Treatment

View More

Innovations in HR+/HER2– Metastatic Breast Cancer: Advancing Care Through PROTAC ER Degradation

View More

Community Practice Connections™: Translating Evidence to Clinical Practice in Early-Stage HR+, HER2- Breast Cancer

View More

Community Practice Connections™: Exploring Emerging Next-Generation Endocrine Therapies in ER+/HER2- Breast Cancer – Evaluating the Potential of Future of Treatment

View More

Community Practice Connections™: Navigating the Impact of HER2, HER3 and TROP2 from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

View More

Clinical Case Vignette Series™: 42nd Annual Miami Breast Cancer Conference®

View More

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

View More

More News